About Pathway Biologic
Pathway Biologic is a company based in Plant City (United States) founded in 2016 was acquired by Plant Response in January 2020. The company has 4 employees as of December 31, 2021. Pathway Biologic operates in a competitive market with competitors including GSK, Avidity Biosciences, Vividion Therapeutics, Sutro Biopharma and Savara Pharma, among others.
- Headquarter Plant City, United States
- Employees 4 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
4
as on Dec 31, 2021
-
Acquired by
Plant Response
(Jan 17, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Pathway Biologic
Detailed funding history for Pathway Biologic
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Pathway Biologic
Pathway Biologic has secured backing from 1 investor. Prominent investors backing the company include Plant Response.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biological farm inputs are manufactured and distributed for plant health.
|
Locked | Locked | Locked |
Investor details for Pathway Biologic
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pathway Biologic
Investment portfolio details for Pathway Biologic
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Pathway Biologic
Detailed financials for Pathway Biologic
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pathway Biologic Comparisons
Peer comparison for Pathway Biologic
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pathway Biologic
Pathway Biologic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Vividion Therapeutics, Sutro Biopharma and Savara Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Therapeutics for rare respiratory diseases are developed by Savara Pharma.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
Detailed competitors of Pathway Biologic
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pathway Biologic
Complete news archive for Pathway Biologic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pathway Biologic
Pathway Biologic was founded in 2016.
Pathway Biologic is headquartered in Plant City, United States. It is registered at Plant City, Florida, United States.
As of Dec 31, 2021, the latest employee count at Pathway Biologic is 4.
Pathway Biologic was established in 2016 in Plant City, United States, as an applied microbial science company. A comprehensive library of microbial strains has been created through characterization and performance testing of thousands of isolates. These strains are deployed in sectors including agriculture, biotechnology, feed additives, aquaculture, and bioremediation to address industrial and environmental applications. Operations focus on fermentation technology for product development.
Pathway Biologic's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Pathway Biologic has 1 investor. Key investors include Plant Response.